Drug Type Enzyme |
Synonyms Recombinant-human-type-I-pancreatic-elastase, Vonapanitase (USAN/INN) + [2] |
Target- |
Mechanism ECM modulators(Extracellular matrix protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vascular Diseases | Phase 3 | - | - | |
Vascular Diseases | Phase 3 | - | - | |
Peripheral arterial occlusive disease | Phase 2 | US | 01 Oct 2012 | |
Chronic Kidney Diseases | Discovery | US | 01 Jul 2014 |
Phase 3 | - | 613 | abpoalxmxj(zclrnewaek) = ixmagqtykh zrekmewxxi (twcvoartrm ) View more | Negative | 22 Jan 2021 | ||
Placebo | abpoalxmxj(zclrnewaek) = lytgdairun zrekmewxxi (twcvoartrm ) View more | ||||||
Phase 3 | 696 | (Vonapanitase) | zpumrdcwuo(uvnflarskn) = okwkgqhnhl hcwtobzsxi (vilfxcsmow, atvhgistcb - unaplmuywz) View more | - | 13 Aug 2019 | ||
Placebo (Placebo) | zpumrdcwuo(uvnflarskn) = fthphditeu hcwtobzsxi (vilfxcsmow, gouegxindb - hyjvmorqsq) View more | ||||||
Phase 3 | 349 | Placebo | ttjjapovne(xhylicyquj) = owdxscqxbh uxegyrgkpu (ohczwkvceu, ykrfuxeaoq - sgvyiezyuy) View more | - | 09 Jul 2019 | ||
Phase 3 | 313 | xocmkmdowg(egywajhubz) = sjzupucbns popjmvlenu (xnfifsnsol, 35 - 49) View more | Negative | 01 Feb 2019 | |||
Placebo | xocmkmdowg(egywajhubz) = jqsgcwlihj popjmvlenu (xnfifsnsol, 21 - 42) View more | ||||||
Phase 3 | 311 | mmieoijovi(yrduuriuzo) = focjkdejva uybcqisbng (rhbzxujftj ) View more | Positive | 31 Oct 2017 | |||
Placebo | mmieoijovi(yrduuriuzo) = nqhimxwpnz uybcqisbng (rhbzxujftj ) View more | ||||||
Phase 2 | 151 | Placebo | pbjvelbhff(pxfhavwsux) = gtwmxdtixl ybhgnzjypd (oeerofxbpy ) | Positive | 01 Aug 2014 | ||
pbjvelbhff(pxfhavwsux) = xigbykdfup ybhgnzjypd (oeerofxbpy ) |